S&P 500 7,581.46 −0.51%
Nasdaq 26,004.72 −0.69%
S&P/TSX 35,475.63 −0.64%
Apple 329.32 −1.13%
Nvidia 212.82 +0.88%
Microsoft 499.05 −1.26%
Shopify 181.80 −2.35%
Royal Bank 283.20 −0.70%
CAD/USD 0.7185 −0.37%
LIVE · 10:40 ET
Market ClerkRecap
Tue Sep 15 · markets open4 signals today278 insider buys this week · $437.8MCIRO short report next: Sep 30The week ahead
MD
INSIDER · RYTM · RHYTHM PHARMACEUTICALS, INC. · PRESIDENT AND CEO

Meeker David P

Every open-market transaction filed under this name, Sep 14 to Sep 14.

Filings
5
0 buys · 5 sells
Bought
open market, at cost
Sold
$5.1M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 14RYTMRHYTHM PHARMACEUTICALS, INC.President and CEOSell2,300$105.19$242K−7.3%
Sep 14RYTMRHYTHM PHARMACEUTICALS, INC.President and CEOSell1,817$104.55$190K−6.8%
Sep 14RYTMRHYTHM PHARMACEUTICALS, INC.President and CEOSell8,698$103.43$900K−5.7%
Sep 14RYTMRHYTHM PHARMACEUTICALS, INC.President and CEOSell30,746$102.35$3.1M−4.7%
Sep 14RYTMRHYTHM PHARMACEUTICALS, INC.President and CEOSell6,439$101.75$655K−4.2%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.